Aurora introduces medical cannabis pastilles for patient relief in australia

Nasdaq | tsx: acb canada's leading medical cannabis company and medreleaf australia launch innovative product to offer greater choice for patients edmonton, ab , march 4, 2024 /prnewswire/ - aurora cannabis inc. (nasdaq: acb) (tsx: acb) – the canadian based leading global medical cannabis company, together with subsidiary company, medreleaf australia, have announced today the availability of medical cannabis pastilles for doctors to prescribe to patients in australia. the novel product is produced by aurora and distributed by medreleaf australia, a leading distributor of medical cannabis products with the number two position in the australian market.
ACB Ratings Summary
ACB Quant Ranking